S 1360

Drug Profile

S 1360

Alternative Names: 810781; GW810781; S1360

Latest Information Update: 06 Aug 2003

Price : $50

At a glance

  • Originator Shionogi
  • Class Antivirals
  • Mechanism of Action HIV integrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 06 Aug 2003 Discontinued - Phase-II for HIV infections treatment in USA (PO)
  • 05 Nov 2002 A clinical study has been added to the adverse events and pharmacokinetics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top